Skip to main content

vTv Therapeutics wins FDA Breakthrough Therapy designation for type 1 diabetes treatment

A new type 1 diabetes therapy developed by a Triad biomedical company helps minimize hypoglycemia resulting from treatment of the disease. It has earned FDA Breakthrough Therapy designation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.